other drugs Flashcards

1
Q

what is the cephalosporins’ broad spectrum

A

Activity against transpeptidases of different bacterial species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the features of aminoglycosides

A

Bactericidal
Gentamicin
Nephrotoxicity, ototoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the features of tetracylines

A

Bacteriostatic – broad spectrum
Doxycycline, minocycline
Phototoxicity, chelation* of metal ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does phototoxic mean?

A

toxic effect triggered by exposure to light chemically induced skin irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what drugs are inhibitors of DNA replication

A

Quinolones,metronidazoles, rifampicin, antimetabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are examples of quinolones?

A

Ciprofloxacin, nalidixic acid, norfloxacin, ofloxacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what do quinolones do?

A

Inhibition of enzymes (DNA gyrases) needed for supercoiling, replication and separation of circular bacterial DNA - Rapid bacterial cell death
˃˃G-, G+, anaerobes, Mycoplasma, Chlamydia (depending on the quinolone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the uses of quinolones

A

urinary tract infections (not first line), pseudomonal infection, gastrointestinal infections, prostatitis, sexually transmitted infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are DNA gyrases

A

essential (and mainly) bacterial enzymes that catalyse the ATP-dependent negative supercoiling of double-stranded closed-circular DNA. Gyrase belongs to a class of enzymes known as topoisomerases that are involved in the control of topological transitions of DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are metronidazoles

A

Prodrug – only anaerobic organisms can metabolite to its active form
Metabolites produced are toxic to DNA – bactericidal
Considered potentially mutagenic, carcinogenic, and teratogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is rifampicin

A

Bactericidal – Mycobacteria (M. tuberculosis, M. leprae)
Binds to RNA polymerase → inhibits mRNA synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what does mutagenic mean

A

capable of inducing mutation or increasing its rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what does teratogenic mean

A

may produce physical or functional defects in the human embryo or foetus/ potential to cause malformations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is synergistic association

A

interaction or cooperation of two or more organisations, substances, or other agents to produce a combined effect greater than the sum of their separate effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are antimetabolites

A

drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what happens when sulfonamide and trimethorpin interact

A

Sulfonamide + trimethoprim → synergistic** association
Act in the same pathway (different stages) - Synthesis of tetrahydrofolate

17
Q

features of sulfanomides and trimethoprim

A

Bacteriostatic
Co-trimoxazole may be bactericidal and resistance is not common

18
Q

what are mechanisms of antibiotic resistance

A

Inactivation or modification of the antibiotic
Alteration of microbial enzymes that transform pro-drugs to the effective moieties
Alteration of the target
Reduced uptake of the antibiotic
Enhanced export of the antibiotic (efflux pumps)
Development of alternative pathways

19
Q

what ways has antibiotic resistance impacted the treatment of patients

A

Promoting the development of new antibiotics and new diagnostic tests for resistant bacteria
NICE guidance